Aprepitant Capsules and Dextenza intraocular
Determining the interaction of Aprepitant Capsules and Dextenza intraocular and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: aprepitant
Brand name: Cinvanti, Emend, Emend 3-Day, Emend 2-Day
Synonyms: Aprepitant
Generic Name: dexamethasone ophthalmic
Brand name: Dextenza, Dexycu, Ozurdex, Maxidex
Synonyms: Dextenza (intraocular), Dextenza Insert
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Aprepitant Capsules-Dextran 40
- Aprepitant Capsules-Dextran 70 6% in 5% Dextrose high molecular weight
- Aprepitant Capsules-Dextran 75
- Aprepitant Capsules-Dextran high molecular weight
- Aprepitant Capsules-Dextranomer and Hyaluronate Derivatives (Deflux)
- Aprepitant Capsules-Dextranomer and Hyaluronate Derivatives (Solesta)
- Dextenza intraocular-Aprepitant Injection
- Dextenza intraocular-Aprepitant Intravenous
- Dextenza intraocular-Aprepitant Oral Suspension
- Dextenza intraocular-Aprepitant/Fosaprepitant Dimeglumine
- Dextenza intraocular-Apresazide
- Dextenza intraocular-Apresoline